Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,227 | Dovepress* | 6,749+ | 1,349 | 8,098 | |
PubMed Central* | 478 | 163 | 641 | ||
Totals | 7,227 | 1,512 | 8,739 | ||
*Since 14 October 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar